A carregar...

Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines

BACKGROUND: The mTOR inhibitor rapamycin has anti-tumor activity across a variety of human cancers, including hepatocellular carcinoma. However, resistance to its growth inhibitory effects is common. We hypothesized that hepatic cell lines with varying rapamycin responsiveness would show common char...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jimenez, Rosa H., Boylan, Joan M., Lee, Ju-Seog, Francesconi, Mirko, Castellani, Gastone, Sanders, Jennifer A., Gruppuso, Philip A.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2009
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2756589/
https://ncbi.nlm.nih.gov/pubmed/19816606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0007373
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!